A cross-talk between gut microbiome, salt and hypertension

Area of Science:

• Cardiovascular Physiology
• Microbiome Research
• Nutritional Science

Background:

• Cardiac disorders are a leading cause of global mortality.
• Hypertensive patients face elevated cardiovascular disease risk, even with medication.
• Gut microbiome alterations are increasingly linked to cardiovascular physiology.

Purpose of the Study:

• To explore the role of host gut-microbiota in cardiovascular disorders, particularly hypertension.
• To investigate the connection between dietary salt, hypertension, and gut microbiome.
• To identify dietary interventions for managing microbiota and preventing cardiovascular complications.

Main Methods:

• Review of experimental evidence from animal and human studies.
• Analysis of gut microbiome products: short-chain fatty acids (SCFAs) and Trimethyl Amine -N-Oxide (TMAO).
• Examination of the relationship between dietary salt, hypertension, and gut microbial activity.

Main Results:

• Gut microbiota products, SCFAs and TMAO, significantly impact blood pressure regulation and cardiovascular disease pathogenesis.
• A direct link is established between dietary salt intake, hypertension, and gut microbiome composition.
• Specific dietary interventions can modulate gut microbiota to mitigate cardiovascular risks.

Conclusions:

• The gut microbiome plays a critical role in hypertension and cardiovascular health.
• Understanding the gut microbiome offers novel therapeutic targets for hypertension prevention.
• Restoring gut microbiome homeostasis presents a promising strategy for managing cardiovascular complications.